InvestorsObserver
×
News Home

Should You Add MacroGenics Inc (MGNX) Stock to Your Portfolio Tuesday?

Tuesday, November 28, 2023 11:39 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add MacroGenics Inc (MGNX) Stock to Your Portfolio Tuesday?

The 90 rating InvestorsObserver gives to MacroGenics Inc (MGNX) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 97 percent of stocks in the Healthcare sector, MGNX’s 90 overall rating means the stock scores better than 90 of all stocks.

Overall Score - 90
MGNX has an Overall Score of 90. Find out what this means to you and get the rest of the rankings on MGNX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 90 means the stock is more attractive than 90 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With MacroGenics Inc Stock Today?

MacroGenics Inc (MGNX) stock is trading at $7.66 as of 11:38 AM on Tuesday, Nov 28, an increase of $0.01, or 0.13% from the previous closing price of $7.65. The stock has traded between $7.52 and $7.79 so far today. Volume today is less active than usual. So far 47,212 shares have traded compared to average volume of 722,663 shares. Click Here to get the full Stock Report for MacroGenics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App